#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

21/01/2025 1h 1min Episodio 36
#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies

Listen "#36 From Data to Practice: Assessing New Alzheimer's Disease Therapies"

Episode Synopsis

Karl Herrup, Michelle Jin, and James Noble share their perspectives on evaluating the clinical impacts of emerging treatments for Alzheimer's Disease with eNeuro Editor-in-Chief Christophe Bernard. Find our upcoming webinar schedule here. With special guests: Karl Herrup, Michelle Jin, and James Noble Hosted by: Christophe Bernard On Neuro Current, we delve into the stories and conversations surrounding research published in the journals of the Society for Neuroscience. Through its publications, JNeurosci, eNeuro, and the History of Neuroscience in Autobiography, SfN promotes discussion, debate, and reflection on the nature of scientific discovery, to advance the understanding of the brain and the nervous system.  Find out more about SfN and connect with us on X, Instagram, and LinkedIn.  

More episodes of the podcast Neuro Current: An SfN Journals Podcast